Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ALTR
|
Gilma Saravia
Chief People Officer |
SELL
Open market or private sale
|
Direct | 425 Reduced 1.89% |
$47,302
$111.3 p/Share
|
Mar 18
2025 |
ACCD
|
Rajeev Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 289 Reduced 0.03% |
$2,020
$6.99 p/Share
|
Mar 18
2025 |
ACCD
|
Stephen H. Barnes
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 142 Reduced 0.05% |
$992
$6.99 p/Share
|
Mar 18
2025 |
ACCD
|
Robert N Cavanaugh
President |
SELL
Open market or private sale
|
Direct | 181 Reduced 0.08% |
$1,265
$6.99 p/Share
|
Mar 18
2025 |
ARVN
|
Noah Berkowitz
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 8,658 Reduced 7.3% |
$74,372
$8.59 p/Share
|
Mar 18
2025 |
GPS
|
Sarah Gilligan
Chief Sup Chn & Transform Ofcr |
SELL
Open market or private sale
|
Direct | 804 Reduced 18.08% |
$15,750
$19.59 p/Share
|
Mar 18
2025 |
GPS
|
Julie Gruber
Chief Legal&Compliance Officer |
SELL
Open market or private sale
|
Direct | 1,537 Reduced 3.95% |
$30,109
$19.59 p/Share
|
Mar 18
2025 |
GPS
|
Katrina O'Connell
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,365 Reduced 21.76% |
$46,330
$19.59 p/Share
|
Mar 18
2025 |
GPS
|
Chris Blakeslee
President & CEO, Athleta |
SELL
Open market or private sale
|
Direct | 16,980 Reduced 17.1% |
$332,468
$19.58 p/Share
|
Mar 18
2025 |
GPS
|
Mark Breitbard
President & CEO, Gap Brand |
SELL
Open market or private sale
|
Direct | 3,393 Reduced 2.48% |
$66,434
$19.58 p/Share
|
Mar 18
2025 |
FNKO
|
Tracy D Daw
CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 18,608 Reduced 41.41% |
$132,861
$7.14 p/Share
|
Mar 18
2025 |
SMC
|
J Heath Deneke
Chairman, President and CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.36% |
$38,240
$38.24 p/Share
|
Mar 18
2025 |
ZIP
|
Amy Garefis
EVP, Chief People Officer |
SELL
Open market or private sale
|
Direct | 2,690 Reduced 1.27% |
$15,844
$5.89 p/Share
|
Mar 18
2025 |
AI
|
Thomas M Siebel
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 127,991 Reduced 17.63% |
$2,820,921
$22.04 p/Share
|
Mar 18
2025 |
NMIH
|
Nicholas Daniel Realmuto
VP, Controller |
SELL
Open market or private sale
|
Direct | 2,755 Reduced 25.84% |
$97,334
$35.33 p/Share
|
Mar 18
2025 |
ACLX
|
Kavita Patel |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 100.0% |
$107,460
$71.64 p/Share
|
Mar 18
2025 |
RSI
|
Kyle Sauers
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 28,381 Reduced 5.69% |
$303,676
$10.7 p/Share
|
Mar 18
2025 |
LAUR
|
Marcelo Cardoso
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 6,942 Reduced 1.79% |
$132,800
$19.13 p/Share
|
Mar 18
2025 |
HIMS
|
Irene Becklund
PAO |
SELL
Open market or private sale
|
Direct | 8,277 Reduced 44.77% |
$283,983
$34.31 p/Share
|
Mar 18
2025 |
HIMS
|
Soleil Boughton
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 3,236 Reduced 1.83% |
$111,027
$34.31 p/Share
|
Mar 18
2025 |
HIMS
|
Andrew Dudum
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 78,760 Reduced 45.35% |
$2,673,114
$33.94 p/Share
|
Mar 18
2025 |
HIMS
|
Patrick Harrison Carroll
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 23,287 Reduced 10.0% |
$798,976
$34.31 p/Share
|
Mar 18
2025 |
SRE
|
Peter R Wall
SVP, Controller and CAO |
SELL
Open market or private sale
|
Direct | 8,192 Reduced 40.84% |
$580,075
$70.81 p/Share
|
Mar 18
2025 |
CW
|
John C Watts
Vice President Strat & Bus Dev |
SELL
Open market or private sale
|
Direct | 228 Reduced 4.04% |
$74,193
$325.41 p/Share
|
Mar 18
2025 |
CW
|
George P. Mc Donald
VP and Corporate Secretary |
SELL
Open market or private sale
|
Direct | 148 Reduced 7.23% |
$48,160
$325.41 p/Share
|
Mar 18
2025 |
CW
|
Paul J Ferdenzi |
SELL
Open market or private sale
|
Direct | 658 Reduced 3.31% |
$214,297
$325.68 p/Share
|
Mar 18
2025 |
CW
|
Lynn M Bamford
Chair and CEO |
SELL
Open market or private sale
|
Direct | 3,131 Reduced 6.8% |
$1,018,858
$325.41 p/Share
|
Mar 18
2025 |
CW
|
K Christopher Farkas
Vice President and CFO |
SELL
Open market or private sale
|
Direct | 922 Reduced 6.17% |
$300,083
$325.47 p/Share
|
Mar 18
2025 |
CW
|
Kevin Rayment
Vice President and COO |
SELL
Open market or private sale
|
Direct | 1,003 Reduced 3.73% |
$326,707
$325.73 p/Share
|
Mar 18
2025 |
CW
|
Robert F Freda
Vice President and Treasurer |
SELL
Open market or private sale
|
Direct | 136 Reduced 2.74% |
$44,262
$325.46 p/Share
|
Mar 18
2025 |
CW
|
Gary A Ogilby
VP & Corporate Controller |
SELL
Open market or private sale
|
Direct | 200 Reduced 7.22% |
$65,072
$325.36 p/Share
|
Mar 18
2025 |
EPR
|
Mark Alan Peterson
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 13,700 Reduced 0.0% |
$709,249
$51.77 p/Share
|
Mar 18
2025 |
PCYG
|
Randall K Fields
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$96,000
$19.2 p/Share
|
Mar 18
2025 |
JOBY
|
Didier Papadopoulos
President of Aircraft OEM |
SELL
Open market or private sale
|
Direct | 3,710 Reduced 5.41% |
$23,261
$6.27 p/Share
|
Mar 18
2025 |
AFG
|
John I Von Lehman |
SELL
Open market or private sale
|
Direct | 2,542 Reduced 18.66% |
$319,453
$125.67 p/Share
|
Mar 18
2025 |
CTRA
|
Adam M Vela
SVP & General Counsel |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 7.34% |
$230,160
$28.77 p/Share
|
Mar 18
2025 |
VRSK
|
Lee Shavel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,100 Reduced 1.73% |
$318,076
$289.16 p/Share
|
Mar 18
2025 |
AKAM
|
Paul C Joseph
EVP - Global Sales |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 9.7% |
$333,480
$83.37 p/Share
|
Mar 18
2025 |
CNO
|
Gary C Bhojwani
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 27,918 Reduced 8.39% |
$1,144,079
$40.98 p/Share
|
Mar 18
2025 |
CYTK
|
Fady Ibraham Malik
EVP Research & Development |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 1.4% |
$87,160
$43.58 p/Share
|
Mar 18
2025 |
ZVIA
|
Amy Taylor
President & CEO |
SELL
Open market or private sale
|
Direct | 29,079 Reduced 1.89% |
$60,775
$2.09 p/Share
|
Mar 18
2025 |
ZVIA
|
Lorna R. Simms
SVP, GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct | 4,957 Reduced 2.26% |
$10,409
$2.1 p/Share
|
Mar 18
2025 |
KIDS
|
David R Bailey
President and CEO |
SELL
Open market or private sale
|
Direct | 6,620 Reduced 2.03% |
$164,573
$24.86 p/Share
|
Mar 18
2025 |
KIDS
|
Daniel J Gerritzen
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 5,310 Reduced 4.57% |
$132,006
$24.86 p/Share
|
Mar 18
2025 |
KIDS
|
Fred Hite
COO and CFO |
SELL
Open market or private sale
|
Direct | 6,443 Reduced 3.0% |
$160,172
$24.86 p/Share
|
Mar 18
2025 |
KIDS
|
Joseph W Hauser
Pres. Trauma & Def. Correction |
SELL
Open market or private sale
|
Direct | 5,300 Reduced 3.71% |
$131,758
$24.86 p/Share
|
Mar 18
2025 |
KIDS
|
Gregory A Odle
President of Scoliosis |
SELL
Open market or private sale
|
Direct | 5,359 Reduced 3.48% |
$133,224
$24.86 p/Share
|
Mar 18
2025 |
ALTR
|
James Ralph Scapa
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 9 Reduced 0.0% |
$1,001
$111.3 p/Share
|
Mar 17
2025 |
ALTR
|
Nelson Dias
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 1,671 Reduced 2.93% |
$185,982
$111.3 p/Share
|
Mar 17
2025 |
ALTR
|
Jeffrey Marraccini
Officer |
SELL
Open market or private sale
|
Direct | 90 Reduced 1.62% |
$10,017
$111.3 p/Share
|
Mar 17
2025 |